Navigation Links
Salimetrics Cortisol Assay Superior in Comparison Study
Date:9/30/2013

(PRWEB) September 30, 2013

German scientists were seeking to compare studies that used different assays. In their study, published in the January 2013 issue of Psychoneuroendocrinology, they concluded that among commercially available assays, the Salimetrics assay for cortisol exhibits the best linearity and comes closest to the results found in tandem mass spectrometry. They confirmed that the different cortisol assays of Salimetrics, IBL, DRG, DSL and DELFIA produced results which could not be easily compared.

The scientists further suggest the inclusion of nonlinear model components to compensate for the “accuracy decrease towards lower cortisol values” which “is assumed to reflect the impact of cross-reactive saliva matrix antigens, mostly cortisone.”

“Of all the commercially available immunoassays, Salimetrics has the least cross reactivity with cortisone and therefore the Salimetrics product is the most accurate,” Salimetrics Principal Scientist Jon Peterson, Ph.D., explained. He added that “it is the mission of Salimetrics to provide immunoassays that are the standard for saliva-based biomarker research.”

The vast majority of salivary cortisol measurements are determined using immunoassays, the study’s authors, Robert Miller, Franziska Plessow, Manfred Rauh, Michael Groschl and Clemens Kirschbaum, noted. “Due to its non-invasiveness, precision and cost efficiency, the measurement of steroid levels from saliva has become a valuable tool in psychoneuroendocrinological research over the past two decades.” The scientists created models to compare the accuracies of different assay products to liquid chromatography coupled with tandem mass spectroscopy (LC-MS/MS) control results. These models showed that the Salimetrics assay had the lowest interference among the five immunoassays compared.

Salimetrics produces more than 23 biomarkers reliably measured in saliva and has the most comprehensive catalogue of commercially available salivary measures and tools provided by one source. There are distributors available worldwide. Hans Schroeder, Salimetrics CEO, notes that “although the science is complex, the driving force behind Salimetrics is simple: Better Collection. Better Assays. Better Results. Better Science.”

About Salimetrics: Founded in 1998, Salimetrics, LLC supports researchers, the immunodiagnostic industry and functional testing laboratories around the world with innovative salivary immunoassay products and services. Salimetrics’ collection techniques, assay kits and CLIA-certified testing services are used to measure biomarkers related to stress, behavior and development, inflammation, sleep, reproduction, health and immune function, including: alpha-amylase, androstenedione, blood contamination, chromogranin A, cortisol, cotinine, C-reactive protein, DHEA, DHEA-S, estradiol, estriol, estrone, IL-1b, IL-6, melatonin, NGF, progesterone, 17a-hydroxyprogesterone, secretory IgA, testosterone, and TNF-a. Salimetrics also provides salivary DNA analysis. The company is based in State College, Pennsylvania, with offices in the UK and distributors around the world. For more information, visit Salimetrics on the web at http://www.salimetrics.com.

Read the full story at http://www.prweb.com/releases/salivary_cortisol_EIA/2013/prweb11171988.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quality Salivary Research with the Salimetrics Center of Excellence Program
2. Salimetrics Offers New Saliva Collection Aid for Easy Collection of Passive Drool Samples
3. Salimetrics to Present Workshop on the Integration of Salivary Analytes into Scientific Studies at the Society for Research in Child Development (SRCD) Preconference
4. Full Service CRO DAaCRO Joins Salimetrics Center of Excellence Program
5. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
6. Salimetrics Launches a Better Salivary IL-6 ELISA/EIA Kit
7. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
8. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
9. HistoRx Licenses Melanoma Assay from Yale University
10. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
11. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... a United States multicenter, prospective clinical study that demonstrates the accuracy of ... capable of identifying clinically significant acute bacterial and viral respiratory tract infections ...
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... ... 2017 , ... At its national board meeting in North ... the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology and ... ARCS Alumni Hall of Fame . ASTER Labs is a technology development ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):